SARA WILLIAMS: Open Payments
NPI 1336857390 · FLORA, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 33 payments from 8 companies in 2025. Trend: 2023 $290 · 2024 $369 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $195 |
| Alkermes, Inc. | 10 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $127 |
| Otsuka America Pharmaceutical, Inc. | 4 | $92 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $14 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: COBENFY, ARISTADA, CAPLYTA, REXULTI, ABILIFY MAINTENA, AUSTEDO XR, FANAPT, LYBALVI.
Industry payments across IL — which companies pay providers there.
